Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inhee Mook-Jung

Showing results (151-160 of 181) with videos related to

Pageof 19
Sort By:
Stem Cells Translational Medicine|February 8, 2017
Protein-Induced Pluripotent Stem Cells Ameliorate Cognitive Dysfunction and Reduce Aβ Deposition in a Mouse Model of Alzheimer's DiseaseMoon-Yong Cha, Yoo-Wook Kwon, Hyo-Suk Ahn, et al.
Autophagy|December 21, 2017
Regulation of autophagic proteolysis by the N-recognin SQSTM1/p62 of the N-end rule pathwayHyunjoo Cha-Molstad, Su Hyun Lee, Jung Gi Kim, et al.
Neurobiology of Aging|February 4, 2014
Migration of neutrophils targeting amyloid plaques in Alzheimer's disease mouse modelSung Hoon Baik, Moon-Yong Cha, Young-Min Hyun, et al.
Progress in Neurobiology|October 13, 2019
Prognostic plasma protein panel for Aβ deposition in the brain in Alzheimer's diseaseJong-Chan Park, Sun-Ho Han, Hangyeore Lee, et al.
Experimental & Molecular Medicine|January 21, 2022
Application of QPLEX<sup>TM</sup> biomarkers in cognitively normal individuals across a broad age range and diverse regions with cerebral amyloid depositionDongjoon Lee, Jong-Chan Park, Keum Sim Jung, et al.
Journal of Neuroinflammation|April 23, 2026
Tryptophan-kynurenine metabolic reprogramming along the gut-brain axis alleviates Alzheimer's pathologyHyunjung Choi, Seok Beom Hong, Yumi Kim, et al.
Alzheimer'S Research & Therapy|March 24, 2017
Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid depositionJong-Chan Park, Sun-Ho Han, Hyun Jin Cho, et al.
Experimental & Molecular Medicine|June 10, 2021
The clinical use of blood-test factors for Alzheimer's disease: improving the prediction of cerebral amyloid deposition by the QPLEX<sup>TM</sup> Alz plus assay kitHaeng Jun Kim, Jong-Chan Park, Keum Sim Jung, et al.
Journal of Alzheimer'S Disease : JAD|July 10, 2016
PiB-PET Imaging-Based Serum Proteome Profiles Predict Mild Cognitive Impairment and Alzheimer's DiseaseSeokjo Kang, Hyobin Jeong, Je-Hyun Baek, et al.
Nature Communications|January 13, 2021
A logical network-based drug-screening platform for Alzheimer's disease representing pathological features of human brain organoidsJong-Chan Park, So-Yeong Jang, Dongjoon Lee, et al.
Pageof 19

Showing results (151-160 of 181) with videos related to

Sort By:
Pageof 19
Stem Cells Translational Medicine|February 8, 2017
Protein-Induced Pluripotent Stem Cells Ameliorate Cognitive Dysfunction and Reduce Aβ Deposition in a Mouse Model of Alzheimer's DiseaseMoon-Yong Cha, Yoo-Wook Kwon, Hyo-Suk Ahn, et al.
Autophagy|December 21, 2017
Regulation of autophagic proteolysis by the N-recognin SQSTM1/p62 of the N-end rule pathwayHyunjoo Cha-Molstad, Su Hyun Lee, Jung Gi Kim, et al.
Neurobiology of Aging|February 4, 2014
Migration of neutrophils targeting amyloid plaques in Alzheimer's disease mouse modelSung Hoon Baik, Moon-Yong Cha, Young-Min Hyun, et al.
Progress in Neurobiology|October 13, 2019
Prognostic plasma protein panel for Aβ deposition in the brain in Alzheimer's diseaseJong-Chan Park, Sun-Ho Han, Hangyeore Lee, et al.
Experimental & Molecular Medicine|January 21, 2022
Application of QPLEX<sup>TM</sup> biomarkers in cognitively normal individuals across a broad age range and diverse regions with cerebral amyloid depositionDongjoon Lee, Jong-Chan Park, Keum Sim Jung, et al.
Journal of Neuroinflammation|April 23, 2026
Tryptophan-kynurenine metabolic reprogramming along the gut-brain axis alleviates Alzheimer's pathologyHyunjung Choi, Seok Beom Hong, Yumi Kim, et al.
Alzheimer'S Research & Therapy|March 24, 2017
Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid depositionJong-Chan Park, Sun-Ho Han, Hyun Jin Cho, et al.
Experimental & Molecular Medicine|June 10, 2021
The clinical use of blood-test factors for Alzheimer's disease: improving the prediction of cerebral amyloid deposition by the QPLEX<sup>TM</sup> Alz plus assay kitHaeng Jun Kim, Jong-Chan Park, Keum Sim Jung, et al.
Journal of Alzheimer'S Disease : JAD|July 10, 2016
PiB-PET Imaging-Based Serum Proteome Profiles Predict Mild Cognitive Impairment and Alzheimer's DiseaseSeokjo Kang, Hyobin Jeong, Je-Hyun Baek, et al.
Nature Communications|January 13, 2021
A logical network-based drug-screening platform for Alzheimer's disease representing pathological features of human brain organoidsJong-Chan Park, So-Yeong Jang, Dongjoon Lee, et al.
Pageof 19